dr. pennell on the evolution of targeting her2 in lung cancer
Published 3 years ago • 315 plays • Length 2:22Download video MP4
Download video MP3
Similar videos
-
2:12
dr. pennell on the evolution of targeted treatment in nsclc
-
17:15
her2 targeted therapy for treatment of nsclc
-
1:41
dr. pennell on remaining challenges in nsclc
-
2:26
dr. pennell on the underutilization of genetic testing in lung cancer
-
1:45
strategies to target her2 in lung cancer
-
5:49
targeting her2 mutations in nsclc: what do we know?
-
1:22
dr. pennell on challenges with ngs in lung cancer
-
3:06
exploring estrogen receptor roles and targeted therapy in nsclc
-
2:10
dr. pennell on importance of egfr testing in nsclc
-
1:39
dr. pennell on benefits of liquid biopsies in lung cancer
-
2:11
dr. pennell on considerations for immediate treatment in lung cancer
-
1:13
dr. pennell on the economic impact of next-generation sequencing
-
1:29
dr. bertino on the impact of the egfr-mutated subset analysis of impower150 in nsclc
-
1:13
challenges to targeting her2 in lung cancer
-
1:53
dr. pennell on the risks associated with sequential therapy with immunotherapy/tkis in lung cancer
-
1:12
dr. yorio on t-dm1 in her2-mutant lung cancer treatment
-
1:18
dr. lopategui on the evolution of targeted therapies in nsclc
-
1:55
dr. gandara on the impact of immunotherapy on the tumor microenvironment in lung cancer
-
6:45
evolution of ngs testing in lung cancers